Veranstaltungen

28. April 2021, 17:30 bis 19:30

i²c Founder&Investor Talk # 65: Ana Teresa Freitas (CEO & Co-founder HeartGenetics)

Podiumsdiskussion

The engineers abroad: adventures of an entrepreneur in the hostile lands of personalized medicine

 

Personalized medicine is nowadays more than a buzzword, as it has become a vision that can be realized by building tools, interventions and products tailored to the individual person or patient, based on their predicted response or potential risk of disease.

More about Ana Teresa Freitas:

Ana Teresa Freitas is CEO and Co-founder of HeartGenetics, Genetics and Biotechnology SA, since 2013. Presently HeartGenetics is part of ImpactLab Group. She is also a Full Professor at the Department of Computer Science and Engineering at Técnico Lisboa (IST), University of Lisbon. She holds a Ph.D. in Computer and Electronic Engineering. She has a degree in Innovation and Entrepreneurship from Católica School of Business and Economics. As a Professor at IST since 1995, she developed the Computational Biology field. Her scientific expertise is in the areas of Bioinformatics, Nutrigenetics, Human genetics, Health Informatics, Algorithms, and Data Mining.

In the context of the Computational Biology field in Europe, she was Vice-chair of the Board for 2017 and Board member (2010-2017) representing Portugal at ESFRI ELIXIR. ELIXIR unites Europe’s leading life science organisations in managing and safeguarding the increasing volume of data being generated by publicly-funded research.

The Talk will focus on:

The engineers abroad: adventures of an entrepreneur in the hostile lands of personalized medicine

Personalized medicine is nowadays more than a buzzword, as it has become a vision that can be realized by building tools, interventions and products tailored to the individual person or patient, based on their predicted response or potential risk of disease.

A field with this description looks like the perfect space for engineers to intervene. This is particularly true if we think that any business around this topic should use digital technologies in order to be scalable and attract investment. Alas, things are not so simple and reality differs from this perception.

In this talk, I will present the work that, as an engineer, I have been developing at HeartGenetics, in the difficult field of personalized and preventive medicine. I will describe the adventure of moving from academia to the industry and how difficult it is to guarantee the convergence of several key factors: the engineer’s vision of a new medical product, the soundness of the underlying science, the need for patient-oriented medical practice, and, finally, the standardization and process efficiency needed to achieve scale and attract investors.

TU Wien I²C

Kalendereintrag

Veranstaltungsort

Online
0000 Vienna
Online

 

Veranstalter

Tu Wien Innovation Incubation Center
Alexandra Negoescu
alexandra.negoescu@tuwien.ac.at

 

Info-Link

https://i2c.tuwien.ac.at/event/i%c2%b2c-fi-talk-65-ana-teresa-freitas-ceo-co-founder-heartgenetics/

 

Öffentlich

Ja

 

Kostenpflichtig

Nein

 

Anmeldung erforderlich

Ja

After registering, please check your inbox as we will have sent you the webinar link and more instructions via the email address you will have registered with. In case you haven't received one in your inbox, please check your SPAM folder (it may happen that the emails sent to the TU Wien e-mail address via Eventbrite end up there).